Suppr超能文献

比较辅助使用地塞米松与甘油以改善细菌性脑膜炎临床结局的研究的荟萃分析。

Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis.

作者信息

Vaziri Siavash, Mansouri Fiezollah, Sayad Babak, Ghadiri Keyghobad, Torkashvand Elham, Rezaei Mansour, Najafi Farid, Azizi Mohsen

机构信息

Department of Infectious and Tropical Disease, School of Medicine, Kermanshah, Iran.

Department of Biostatistics and Epidemiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

J Res Med Sci. 2016 Apr 8;21:22. doi: 10.4103/1735-1995.179890. eCollection 2016.

Abstract

BACKGROUND

Neurological complications are a problematic factor in acute bacterial meningitis; hence, its prevention is the key to ensure the success of meningitis treatment. Glycerol and dexamethasone are both applied in this regard. Oral glycerol is an appropriate alternative instead of intravenous dexamethasone because it does not have problems related to intravenous injection, the high cost, and drug complications. The main objective of this study was to compare the efficacy of adjuvant dexamethasone versus glycerol in order to improve the clinical outcome of bacterial meningitis.

MATERIALS AND METHODS

We conducted a search on the available resources including PubMed, Ovid, Elsevier, Cochrane, and another search engines such as Google till 2014. All clinical trials that were performed in the field of comparing the effectiveness of the two drugs and met the inclusion criteria were gathered and after extraction the relative risk (RR) values, the pooled RR was calculated. The main outcome was neurological complications. Meta-analysis of the data was performed in Stata version 11.2 using both fixed and random effect models, weighting each study by inverse of variance.

RESULTS

In 5 comparative studies (1,340 patients), the rate of neurological complications of glycerol compared to that of dexamethasone was 1.02 [95% confidence interval (CI), 0.98 compared to 1.12]. The rate of neurological complications of dexamethasone compared to dexamethasone + glycerol was 1 (95% CI, 0.97 compared to 1.03), dexamethasone compared to placebo was 0.99 (95% CI, 0.97 compared to 1.03), glycerol compared to glycerol + dexamethasone was 0.98 (95% CI, 0.94 compared to 1.02), and glycerol compared to placebo was 0.97 (95% CI, 0.94 compared to 1.01). In these studies, no difference was reported between dexamethasone and glycerol in terms of reducing neurological complications.

CONCLUSION

Although there were some weak evidences for the nonstatistical significant effect of glycerol in the prevention of neurologic complication after meningitis, there was no difference between glycerol and dexamethasone.

摘要

背景

神经并发症是急性细菌性脑膜炎中的一个问题因素;因此,预防神经并发症是确保脑膜炎治疗成功的关键。甘油和地塞米松在这方面都有应用。口服甘油是静脉用地塞米松的合适替代方案,因为它不存在与静脉注射相关的问题、成本高以及药物并发症等问题。本研究的主要目的是比较辅助使用地塞米松与甘油的疗效,以改善细菌性脑膜炎的临床结局。

材料与方法

我们对包括PubMed、Ovid、爱思唯尔、考克兰等在内的可用资源以及谷歌等其他搜索引擎进行了检索,截至2014年。收集了在比较这两种药物有效性领域进行的所有符合纳入标准的临床试验,并在提取相对风险(RR)值后,计算合并RR。主要结局是神经并发症。使用固定效应模型和随机效应模型在Stata 11.2版本中对数据进行荟萃分析,以方差倒数对每项研究进行加权。

结果

在5项比较研究(1340例患者)中,甘油组与地塞米松组相比的神经并发症发生率为1.02[95%置信区间(CI),0.98比1.12]。地塞米松组与地塞米松+甘油组相比的神经并发症发生率为1(95%CI,0.97比1.03),地塞米松组与安慰剂组相比为0.99(95%CI,0.97比1.03),甘油组与甘油+地塞米松组相比为0.98(95%CI,0.94比1.02),甘油组与安慰剂组相比为0.97(95%CI,0.94比1.01)。在这些研究中,地塞米松和甘油在减少神经并发症方面未报告有差异。

结论

尽管有一些微弱证据表明甘油在预防脑膜炎后神经并发症方面有非统计学显著效果,但甘油和地塞米松之间没有差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1be8/5122109/00ea1eb0f319/JRMS-21-22-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验